Publication: Could fifty percent tumor viability be a good prognostic factor?
dc.contributor.coauthor | Cesur, Ekin Ezgi | |
dc.contributor.coauthor | Özer, Kadir Burak | |
dc.contributor.coauthor | Mandel, Nil Molinas | |
dc.contributor.department | N/A | |
dc.contributor.kuauthor | Erus, Suat | |
dc.contributor.kuauthor | Bulutay, Pınar | |
dc.contributor.kuauthor | Selçukbiricik, Fatih | |
dc.contributor.kuauthor | Tanju, Serhan | |
dc.contributor.kuauthor | Fırat, Pınar Arıkan | |
dc.contributor.kuauthor | Dilege, Şükrü | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Teaching Faculty | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.unit | Koç University Hospital | |
dc.contributor.yokid | 175565 | |
dc.contributor.yokid | 133565 | |
dc.contributor.yokid | 202015 | |
dc.contributor.yokid | 214690 | |
dc.contributor.yokid | 207545 | |
dc.contributor.yokid | 122573 | |
dc.date.accessioned | 2024-11-09T23:44:58Z | |
dc.date.issued | 2022 | |
dc.description.abstract | N/A | |
dc.description.indexedby | WoS | |
dc.description.issue | 9 | |
dc.description.openaccess | NO | |
dc.description.publisherscope | International | |
dc.description.volume | 17 | |
dc.identifier.doi | 10.1016/j.jtho.2022.07.486 | |
dc.identifier.eissn | 1556-1380 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.quartile | Q1 | |
dc.identifier.uri | https://doi.org/10.1016/j.jtho.2022.07.486 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/13757 | |
dc.identifier.wos | 858678100472 | |
dc.keywords | Neoadjuvant therapy | |
dc.keywords | Tumor viability | |
dc.keywords | Lung cancer | |
dc.language | English | |
dc.publisher | Elsevier Science Inc | |
dc.source | Journal of Thoracic Oncology | |
dc.subject | Oncology | |
dc.subject | Respiratory system | |
dc.title | Could fifty percent tumor viability be a good prognostic factor? | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0002-6162-3266 | |
local.contributor.authorid | 0000-0001-5497-1513 | |
local.contributor.authorid | 0000-0002-1273-1674 | |
local.contributor.authorid | 0000-0002-2363-233X | |
local.contributor.authorid | 0000-0001-8340-2678 | |
local.contributor.authorid | 0000-0002-1071-5291 | |
local.contributor.kuauthor | Erus, Suat | |
local.contributor.kuauthor | Bulutay, Pınar | |
local.contributor.kuauthor | Selçukbiricik, Fatih | |
local.contributor.kuauthor | Tanju, Serhan | |
local.contributor.kuauthor | Fırat, Pınar Arıkan | |
local.contributor.kuauthor | Dilege, Mustafa Şükrü |